版本:
中国

BRIEF-Spectrum Pharmaceuticals says PDUFA date set for Qapzola NDA is Dec. 11

Sept 14 Spectrum Pharmaceuticals Inc:

* FDA advisory committee votes that Qapzola (apaziquone) has not shown substantial evidence of a treatment effect over placebo

* FDA is expected to make a final decision by PDUFA date of December 11, 2016 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐